LaFleur & Godfrey’s ResMed RMD Stock Holding History

LaFleur & Godfrey’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,443	Closed	-$2.43M	–	142
2023 Q3	$2.43M	Sell	16,443 -10,468	-39%	-$1.89M	0.39%	61
2023 Q2	$5.88M	Sell	26,911 -2,635	-9%	-$587K	0.88%	36
2023 Q1	$6.47M	Sell	29,546 -967	-3%	-$210K	1.06%	29
2022 Q4	$6.35M	Buy	30,513 +1,063	+4%	+$234K	1.06%	31
2022 Q3	$6.43M	Sell	29,450 -476	-2%	-$108K	1.15%	31
2022 Q2	$6.27M	Buy	29,926 +2,580	+9%	+$549K	0.99%	35
2022 Q1	$6.63M	Buy	27,346 +4,453	+19%	+$1.08M	0.89%	36
2021 Q4	$5.96M	Buy	22,893 +10	+0%	+$2.6K	0.76%	42
2021 Q3	$6.03M	Sell	22,883 -8,540	-27%	-$2.34M	0.83%	39
2021 Q2	$7.75M	Buy	31,423 +1,404	+5%	+$295K	1.11%	33
2021 Q1	$5.82M	Buy	30,019 +20,620	+219%	+$4.13M	1.13%	35
2020 Q4	$2M	Buy	9,399 +4,565	+94%	+$910K	0.41%	48
2020 Q3	$829K	Sell	4,834 -30,034	-86%	-$5.55M	0.19%	73
2020 Q2	$6.7M	Sell	34,868 -1,690	-5%	-$277K	1.71%	25
2020 Q1	$5.38M	Sell	36,558 -10,443	-22%	-$1.66M	1.61%	26
2019 Q4	$7.28M	Sell	47,001 -3,815	-8%	-$550K	1.64%	25
2019 Q3	$6.87M	Sell	50,816 -9,700	-16%	-$1.27M	1.68%	25
2019 Q2	$7.38M	Sell	60,516 -135	-0.2%	-$15K	1.84%	21
2019 Q1	$6.31M	Buy	60,651 +1,501	+3%	+$155K	1.63%	25
2018 Q4	$6.74M	Sell	59,150 -4,970	-8%	-$532K	1.9%	23
2018 Q3	$7.4M	Sell	64,120 -430	-0.7%	-$47.1K	1.78%	24
2018 Q2	$6.69M	Sell	64,550 -2,040	-3%	-$206K	1.67%	26
2018 Q1	$6.56M	Sell	66,590 -3,505	-5%	-$331K	1.64%	26
2017 Q4	$5.94M	Buy	70,095 +845	+1%	+$69.8K	1.46%	24
2017 Q3	$5.33M	Sell	69,250 -140	-0.2%	-$10.7K	1.4%	25
2017 Q2	$5.4M	Buy	69,390 +3,795	+6%	+$272K	1.42%	26
2017 Q1	$4.72M	Buy	65,595 +33,450	+104%	+$2.31M	1.27%	30
2016 Q4	$2M	Buy	32,145 +28,000	+676%	+$1.71M	0.56%	49
2016 Q3	$269K	Sell	4,145 -55,942	-93%	-$3.72M	0.08%	68
2016 Q2	$3.8M	Sell	60,087 -1,161	-2%	-$68.4K	1.12%	30
2016 Q1	$3.54M	Sell	61,248 -3,130	-5%	-$177K	1.08%	31
2015 Q4	$3.46M	Sell	64,378 -575	-0.9%	-$32.4K	1.02%	33
2015 Q3	$3.31M	Buy	64,953 +435	+0.7%	+$23.4K	0.99%	34
2015 Q2	$3.64M	Sell	64,518 -2,104	-3%	-$133K	1.01%	32
2015 Q1	$4.78M	Sell	66,622 -15,860	-19%	-$1.03M	1.28%	31
2014 Q4	$4.62M	Sell	82,482 -10,615	-11%	-$554K	1.24%	30
2014 Q3	$4.59M	Sell	93,097 -13,890	-13%	-$707K	1.26%	28
2014 Q2	$5.42M	Sell	106,987 -11,150	-9%	-$553K	1.44%	25
2014 Q1	$5.28M	Sell	118,137 -34,975	-23%	-$1.57M	1.46%	23
2013 Q4	$7.21M	Buy	153,112 +20,686	+16%	+$1.05M	1.99%	16
2013 Q3	$7M	Buy	132,426 +41,106	+45%	+$1.99M	2.01%	18
2013 Q2	$4.12M	Buy	+91,320	New	+$4.33M	1.23%	29

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LaFleur & Godfrey's RMD Position: Q4 2023 in Review

LaFleur & Godfrey sold out of ResMed (RMD) in Q4 2023, closing a stake of 16,443 shares — an estimated $2.43M sold.

LaFleur & Godfrey first reported a position in RMD in Q2 2013 and held it in 42 quarters. The position peaked at $7.75M in Q2 2021. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

LaFleur & Godfrey reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
LaFleur & Godfrey sold 16,443 ResMed shares in Q4 2023, an estimated $2.43M.
LaFleur & Godfrey first reported a position in ResMed in Q2 2013 and held it in 42 quarters.
LaFleur & Godfrey's ResMed position peaked at $7.75M in Q2 2021.
688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on LaFleur & Godfrey's 13F filing for Q4 2023, filed 18 Jan 2024.